CREB1 and depressive disorder: DEX exposure increased anxiety‐ and depression‐like behaviors and plasma CORT levels, while simultaneous OT treatment blocked the adverse effects of DEX, and upregulated p‐CREB and BDNF levels in the dorsal and ventral hippocampus.